IL-10 Induction from Implants Delivering Pancreatic Islets and Hyaluronan
Open Access
- 1 January 2013
- journal article
- research article
- Published by Wiley in Journal of Diabetes Research
- Vol. 2013, 1-9
Abstract
Local induction of pro-tolerogenic cytokines, such as IL-10, is an appealing strategy to help facilitate transplantation of islets and other tissues. Here, we describe a pair of implantable devices that capitalize on our recent finding that hyaluronan (HA) promotes IL-10 production by activated T cells. The first device is an injectable hydrogel made of crosslinked HA and heparan sulfate loaded with anti-CD3/anti-CD28 antibodies and IL-2. T cells embedded within this hydrogel prior to polymerization go on to produce IL-10in vivo. The second device is a bioengineered implant consisting of a polyvinyl alcohol sponge scaffold, supportive collagen hydrogel, and alginate spheres mediating sustained release of HA in fluid form. Pancreatic islets that expressed ovalbumin (OVA) antigen were implanted within this device for 14 days into immunodeficient mice that received OVA-specific DO.11.10 T cells and a subsequent immunization with OVA peptide. Splenocytes harvested from these mice produced IL-10 upon re-challenge with OVA or anti-CD3 antibodies. Both of these devices represent model systems that will be used, in future studies, to further evaluate IL-10 induction by HA, with the objective of improving the survival and function of transplanted islets in the setting of autoimmune (type 1) diabetes.Keywords
Funding Information
- National Institutes of Health (R01 DK096087, R01 HL113294, U01 AI101984, 4553677)
- National Institutes of Health (R01 DK096087, R01 HL113294, U01 AI101984, 4553677)
- National Institutes of Health (R01 DK096087, R01 HL113294, U01 AI101984, 4553677)
- Klorfine Foundation and Gilbertson Foundation (R01 DK096087, R01 HL113294, U01 AI101984, 4553677)
- Washington State Life Sciences Discovery Fund (R01 DK096087, R01 HL113294, U01 AI101984, 4553677)
This publication has 39 references indexed in Scilit:
- Adoptive Transfer With In Vitro Expanded Human Regulatory T Cells Protects Against Porcine Islet Xenograft Rejection via Interleukin-10 in Humanized MiceDiabetes, 2012
- Rapamycin Combined with Anti-CD45RB mAb and IL-10 or with G-CSF Induces Tolerance in a Stringent Mouse Model of Islet TransplantationPLOS ONE, 2011
- ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursorsProceedings of the National Academy of Sciences, 2011
- Oral Administration of High Molecular Weight Hyaluronan (900 kDa) Controls Immune System via Toll-like Receptor 4 in the Intestinal EpitheliumJournal of Biological Chemistry, 2010
- Recurrence of Type 1 Diabetes After Simultaneous Pancreas-Kidney Transplantation, Despite Immunosuppression, Is Associated With Autoantibodies and Pathogenic Autoreactive CD4 T-CellsDiabetes, 2010
- Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 ReceptorNew England Journal of Medicine, 2009
- CD44 Costimulation Promotes FoxP3+ Regulatory T Cell Persistence and Function via Production of IL-2, IL-10, and TGF-βThe Journal of Immunology, 2009
- Use of Hyaluronan‐Derived Hydrogels for Three‐Dimensional Cell Culture and Tumor XenograftsCurrent Protocols in Cell Biology, 2008
- Recurrence of autoreactive antigen-specific CD4+ T cells in autoimmune diabetes after pancreas transplantationClinical Immunology, 2008
- Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applicationsBiotechnology Letters, 2006